38Indexed trials
mesh condition
Substance-Related Disorders
Intelligence
Substance-Related Disorders intelligence: 38 indexed trials, 11 recruiting studies, 31 sponsors across 13 countries.
11Recruiting
31Sponsors
13Countries
Leading sponsors
Medical University of South Carolina30 recruiting
Johns Hopkins University20 recruiting
Dartmouth-Hitchcock Medical Center20 recruiting
University of California, Los Angeles20 recruiting
University of California, San Francisco21 recruiting
Karolinska Institutet20 recruiting
Jacobs University Bremen gGmbH11 recruiting
Erasmus Medical Center10 recruiting
Centre Hospitalier Universitaire de Nice11 recruiting
Massachusetts General Hospital10 recruiting
Louise Penzenstadler11 recruiting
ER/LA Opioid REMS Program Companies (RPC)10 recruiting
Geographic activity
United States20trials
Sweden2trials
China2trials
France2trials
Austria1trials
South Korea1trials
Spain1trials
Switzerland1trials
United Kingdom1trials
Netherlands1trials
Germany1trials
Hong Kong1trials
Leading interventions
Oxytocin2trials
Saline2trials
Treatment as usual2trials
Adapted Cognitive Behavioral Intervention for Trauma in Schools (CBITS) with a Racial Trauma Module (RTM)1trials
Breathwork-Based Auditory Driving Entropy Module (BADEM)1trials
Bupropion SR1trials
Audiovisual Entrainment1trials
CIDI-51trials
Chinese translated LETS ACT1trials
Cognitive behavioural therapy1trials
Concurrent Treatment with Prolonged Exposure (COPE)1trials
CALM-SUD1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.